2011
DOI: 10.1002/14651858.cd008205.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

Abstract: Hepatic late adverse effects after antineoplastic treatment for childhood cancer Mulder, Renee L.; van Dalen, Elvira C.; Van den Hof, Malon; Bresters, Dorine; Koot, Bart G. P.; Castellino, Sharon M.; Loke, Yoon; Leclercq, Edith; Post, Piet N.; Caron, Huib N.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(7 citation statements)
references
References 174 publications
0
7
0
Order By: Relevance
“…In contrast, the median time between stopping the drug to DILI onset in the remaining 29 confirmed DILI cases was 1 day (range 1–42). There were 13 (22.8%) subjects who had a drug latency exceeding 12 months and the suspect agent in these cases included minocycline (6), atomoxetine (2), valproic acid (2), and 1 case each of fluoxetine, mercaptopurine, and methylphenidate DILI. Thirty‐five percent of the children self‐reported a history of drug allergy that includes drug intolerance but none reported a prior episode of DILI.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, the median time between stopping the drug to DILI onset in the remaining 29 confirmed DILI cases was 1 day (range 1–42). There were 13 (22.8%) subjects who had a drug latency exceeding 12 months and the suspect agent in these cases included minocycline (6), atomoxetine (2), valproic acid (2), and 1 case each of fluoxetine, mercaptopurine, and methylphenidate DILI. Thirty‐five percent of the children self‐reported a history of drug allergy that includes drug intolerance but none reported a prior episode of DILI.…”
Section: Resultsmentioning
confidence: 99%
“…Cardiac related mortality has been reported to increase ≥10-fold among childhood cancer survivors [18][19][20]. Besides, the risk of late hepatic adverse events have also been stressed [18,21,22]. The iron overloading may contribute to these late morbidities in these patients, in addition to contributing potential endocrinopathies such as hypogonadotropic hypogonadism or hypothyroidism, similar to those reported in patients with ␤ thalassemia major [23,24].…”
Section: Discussionmentioning
confidence: 95%
“…Serum bilirubin, prothrombin time and serum albumin were normal from starting of chemotherapy up to completion. 16 The Cochrane Review database shows liver complications to be common during and soon after treatment for childhood cancer. However, about 8-53% of the childhood cancer survivors developed hepatic late adverse effect after treatment.…”
Section: Introductionmentioning
confidence: 99%